Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jsun529
    Member
    • Apr 2009
    • 52

    #1

    SOLiD

    Hi,

    When check the unique.coverage.csv file of the genes, the average coverage is around 5000, how to link this to the actual X coverage that we usual say about NGS, for NGS it only ranges to ~ 100X , is that right ?
    Does this have to take the length of the reference sequence into consideration?

    Thanks,
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    When check the unique.coverage.csv file of the genes, the average coverage is around 5000, how to link this to the actual X coverage that we usual say about NGS, for NGS it only ranges to ~ 100X , is that right ?
    Does this have to take the length of the reference sequence into consideration?
    I don't see how the length of the reference should make a difference. If indeed you are averaging the counts (i.e., each line) within the unique.coverage.csv file and coming up with an average of 5000 reads (per base) then you have an incredibly high coverage. That is what you report. I am not sure where you are getting that the "usual" coverage for NGS is 100x. That is certainly a nice coverage level to have however my 'usual' (with large eukaryote genomes) is below that level.

    Comment

    • jsun529
      Member
      • Apr 2009
      • 52

      #3
      Thanks. Since we are doing targeted resequencing, for the unique.coverage.csv file, most of the position have 0 coverage, i am not sure if it is better to take the 0 out since we do targeted resequencing(only exons+/- small fraction) to do the average, or count it in if I include the 0 coverages then it will be around ~200X. Thanks.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...